Description
Adapsyn’s proprietary drug discovery platform will be applied to the screening of bacteria to discover neuro- and immunomodulatory small molecules to develop therapeutic agents for the treatment of childhood neuropsychiatric disorders.
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $350,000 at start, $661,400 after amendment #3 (+$311,400).
- #02020-07-01$350,000
- #22022-02-21$661,400+$311,400
- #32022-07-11$661,400
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-07-01(start date) | $350,000 | — | Adapsyn’s proprietary drug discovery platform will be applied to the screening of bacteria to discover neuro-… |
| #2 amendment | 2022-02-21 | $661,400 | +$311,400 | Adapsyn’s proprietary drug discovery platform will be applied to the screening of bacteria to discover neuro-… |
| #3 amendment | 2022-07-11 | $661,400 | +$0 | Adapsyn’s proprietary drug discovery platform will be applied to the screening of bacteria to discover neuro-… |
Related records · 10
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 789183498)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2020-2021-Q4-965916 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program | $43,353 | FY2021 |
| 172-2020-2021-Q4-960215 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program | $97,408 | FY2021 |
| 172-2020-2021-Q1-950480 | National Research Council Canada | Conseil national de recherches Canada · Innovation Assistance Program | $81,312 | FY2021 |
| 062-2020-2021-Q3-00241 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Regional Relief and Recovery Fund (RRRF) – Direct | $301,000 | FY2020 |
| 172-2018-2019-Q4-914152 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $72,000 | FY2019 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2020-2021-Q3-956002 · retrieved 2026-11-15.